Filing Details
- Accession Number:
- 0001093557-20-000209
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-27 17:53:03
- Reporting Period:
- 2020-07-23
- Accepted Time:
- 2020-07-27 17:53:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1093557 | Dexcom Inc | DXCM | Surgical & Medical Instruments & Apparatus (3841) | 330857544 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1466545 | Richard Doubleday | 6340 Sequence Drive San Diego CA 92121 | Evp Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-07-23 | 200 | $421.62 | 4,391 | No | 4 | S | Indirect | by Trust |
| Common Stock | Disposition | 2020-07-23 | 83 | $424.63 | 4,308 | No | 4 | S | Indirect | by Trust |
| Common Stock | Disposition | 2020-07-23 | 94 | $425.99 | 4,214 | No | 4 | S | Indirect | by Trust |
| Common Stock | Disposition | 2020-07-23 | 476 | $427.36 | 3,738 | No | 4 | S | Indirect | by Trust |
| Common Stock | Disposition | 2020-07-23 | 107 | $428.52 | 3,631 | No | 4 | S | Indirect | by Trust |
| Common Stock | Disposition | 2020-07-23 | 571 | $429.60 | 3,060 | No | 4 | S | Indirect | by Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | by Trust |
| No | 4 | S | Indirect | by Trust |
| No | 4 | S | Indirect | by Trust |
| No | 4 | S | Indirect | by Trust |
| No | 4 | S | Indirect | by Trust |
| No | 4 | S | Indirect | by Trust |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 51,482 | Direct |
Footnotes
- On June 3, 2019, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee.
- This transaction was executed in multiple trades at prices ranging from $427.20 to $428.13. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- This transaction was executed in multiple trades at prices ranging from $428.24 to $428.82. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- This transaction was executed in multiple trades at prices ranging from $429.38 to $429.82. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Billionaire Hedge Funds
